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Background: Few studies have been undertaken to understand the employment impact in patients with colorectal
cancer and none in middle-aged individuals with cancer. This study described transitions in, and key factors influencing,
work participation during the 12 months following a diagnosis of colorectal cancer.
Methods: We enrolled 239 adults during 2010 and 2011who were employed at the time of their colorectal cancer
diagnosis and were prospectively followed over 12 months. They were compared to an age- and gender-matched
general population group of 717 adults from the Household, Income and Labour Dynamics in Australia (HILDA) Survey.
Data were collected using telephone and postal surveys. Primary outcomes included work participation at 12 months,
changes in hours worked and time to work re-entry. Multivariable logistic and Cox proportional hazards models were
undertaken.
Results: A significantly higher proportion of participants with colorectal cancer (27%) had stopped working at
12 months than participants from the comparison group (8%) (p < 0.001). Participants with cancer who returned
to work took a median of 91 days off work (25–75 percentiles: 14–183 days). For participants with cancer,
predictors of not working at 12 months included: being older, lower BMI and lower physical well-being. Factors
related to delayed work re-entry included not being university-educated, working for an employer with more
than 20 employees in a non-professional or managerial role, longer hospital stay, poorer perceived financial status
and having or had chemotherapy.
Conclusions: In middle-adulthood, those working and diagnosed with colorectal cancer can expect to take
around three months off work. Individuals treated with chemotherapy, without a university degree and from large
employers could be targeted for specific assistance for a more timely work entry.
Trial registration: ACTRN12611000530921
Keywords: Colorectal cancer, Return to work, Employment outcomes, Middle-agedBackground
Each year in Australia over 64,000 cancers, or 56% of all
cancers, are diagnosed in adults of working ages (20–64
years) [1], a proportion which is broadly similar to other
developed countries. Cancer treatments often involve pro-
longed periods of adjuvant therapy and accompanying
side-effects and thus disrupt an individual’s employment,* Correspondence: louisa.gordon@griffith.edu.au
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unless otherwise stated.earnings and other role activities. Although not all pa-
tients wish to return to work, resumption of work is often
seen as a positive step in a cancer survivor’s recovery and
generally signifies a milestone on the patient’s physical
and mental return to their normal activities. A cancer ex-
perience that causes major disruption in the work role can
become a source of high distress and adversely affect
health-related quality of life (HRQoL) and economic se-
curity [2].
Colorectal cancer is the most common cancer in men
and women combined in most Western nations andl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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tions [3]. An experience of colorectal cancer may cause
individuals to have poorer employment outcomes than
for other cancer types (e.g., breast, prostate, skin, lymph-
oma) due to the disease-specific issues that may impact
the ability to perform work [4], such as altered bowel
habits or managing an intestinal stoma. In addition, ad-
juvant chemotherapy is given to approximately 50% of
patients with colorectal cancer [5,6] and during receipt of
this therapy an individual’s work ability can be impeded
through muscle fatigue, anaemia, hair loss, medication ef-
fects, peripheral neuropathy and impaired mental acuity
or ‘chemo brain’ [7]. Many chemotherapies also have im-
munosuppressive properties which may require patients
receiving them to avoid crowds or indoor workplaces [7].
In a recent review of 64 studies that specifically ad-
dressed employment issues following cancer, pooled re-
sults indicated 64% of those working at the time of
diagnosis returned to work after cancer (range 24-94%
in individual studies) [8]. Of those who returned to
work, 40% had continued to work through their treat-
ment or had returned to work by 6 months, 62% were
working at 12 months, 73% by 18 months and 89% by
24 months [9]. Among individuals with different cancer
types, determinants of delayed return to, or stopping
work include: older age [10-12]; physically-demanding
work [10-13]; being female [9-11,13]; presence of comor-
bidities [14]; being married [9,11]; fatigue [14]; lower
education [11,15]; and treatment with chemotherapy [9].
Most of the research to date has concentrated on breast
cancer survivors so the relevance for a colorectal cancer
population is unclear [8].
This study reports the results of a prospective,
population-based study of middle-aged Australian adults
with colorectal cancer and their work experiences. We
have looked at employment outcomes specifically target-
ing individuals aged 45 to 64 years who were still in the
workforce and no other study has done this for any can-
cer population. We chose these individuals because they
will most likely be at a similar stage of life (middle adult-
hood) and therefore not planning immediate retirement
but rather, many would be in the midst of their careers,
with many in senior and managerial roles. In addition,
unlike most studies that focus on medical or socio-
demographic factors as predictors of work return, our
study included many work-related factors that could in-
fluence return to work such as: type of work, work
schedule (e.g., regular daytime, shift-work), type of em-
ployer, workplace size, sick leave provisions, degree of
work autonomy and the level of support from employers
and colleagues. We excluded those aged less than
45 years because colorectal cancer is rare in individuals
less than 45 and these individuals may be less engaged
with the workforce if they have parenting commitmentsto young children. The key aims of the study were to 1)
describe transitions in work participation over a 12-
month period following a primary diagnosis of colorectal
cancer compared to individuals without cancer; 2) iden-
tify the key factors influencing work participation during
or after cancer treatment compared to individuals with-
out cancer; and 3) identify the key factors influencing
time to work re-entry after cancer treatment among indi-
viduals taking work leave as a result of their cancer.
Methods
Study participants
Full details of the study have been previously described
[16]. In brief, a prospective, population-based study en-
rolled middle-aged (45–64 years) men and women who
were in the paid workforce and newly-diagnosed with
colorectal cancer. Participants resided in Queensland,
Australia, were able to complete questions in English,
were enrolled through the Queensland Cancer Registry
between January 2010 and September 2011 and had a
histologically-confirmed diagnosis of colorectal cancer.
Participants were followed for 12 months. These partici-
pants were matched by gender and 5-year age group to
data from a nationally representative sample of compari-
son individuals in the paid workforce who were ran-
domly selected from those who participated in both
Waves 10 (2010) and 11 (2011) of the Household, In-
come and Labour Dynamics in Australia (HILDA) Sur-
vey dataset [17].
Underpinning the study design was the theoretical model
by Steiner et al who proposed a social approach to work
outcomes for cancer survivors where the relationship be-
tween medical/patient factors and work resumption are
moderated by the individual’s work environment and
socio-demographic factors [18]. Ethics approval for the
study was obtained from the Human Ethics Research
Committees of QIMR Berghofer Medical Research
Institute (P1128), Griffith University (MED/19/09/HREC)
and the Queensland Health Research Ethics and Govern-
ance Unit (RD003482).
Data collection and instruments
Cancer group
Data were collected from pathology reports on tumor site
(colon, rectum), histopathological tumor type, degree of
differentiation or grade, degree of metastasis and stage of
disease (i.e., American Joint Committee of Cancer (AJCC)
and Dukes staging). Participants completed structured
telephone interviews at 6 and 12 months after diagno-
sis. At the 6-month data collection time point, partici-
pants recalled work-related information at the time
they were diagnosed with cancer (baseline) while at
12 months they recalled work information since the 6-
month data collection. Interviews were conducted by
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the data collected by telephone interview, and to address
items of a more sensitive nature (i.e., health behaviours,
HRQoL, financial strain), participants completed postal
surveys sent immediately after both telephone interviews.
General population comparison group
Baseline data for the general population group were taken
from the Wave 10 interview (conducted during 2010) and
12 month data from Wave 11 (conducted during 2011).
The HILDA survey data were collected through face-to-
face interviews.
Generic baseline socio-demographic and work status in-
formation were obtained for both the cancer and general
population groups using identical items. Work status
items included questions from validated tools from
Australian government surveys (e.g., Australian Bureau of
Statistics (ABS) Labour Force Survey, ABS 1999 Survey of
Living Standards) [19] and included: employment status,
usual and preferred weekly hours, reasons for working
part-time, occupation, occupation change, industry, paid
leave provisions, employer type, workplace size, work au-
tonomy, perceived financial status. Work transitions were
categorised as four mutually exclusive change categories
from baseline to 12 months: ‘retired/ceased work’ (chan-
ged to 0 hours work), ‘increased work’ (by ≥4 hours per
week), ‘decreased work’ (by ≥4 hours per week) and ‘un-
changed’ (work hours changed by <4 hours per week). A
four-hour margin in work transition categories was
chosen to focus on meaningful changes in hours worked.
The study was statistically powered to detect a 15% differ-
ence in the proportions of work participation across the
cancer and general population groups [16].
Analyses
Baseline socio-demographic and cancer pathology data
were compared for the participants and non-participants,
and between the cancer and general population groups,
using chi-square, Fisher’s exact and t-tests for statistically
significant differences. Descriptive analyses charted em-
ployment transitions from diagnosis to 6- and 12-months
among the cancer group and over 12-months (i.e., the
2010–2011 year period) among the general population
group. The extent of missing data and drop out in the
cancer group was analysed by examining baseline vari-
ables for the ‘completers’ and ‘non-completers’ to identify
possible biases.
Multivariable logistic regression modelling with back-
ward removal of variables identified explanatory variables
(i.e., socio-demographic, clinical and work status variables
outlines above) that were significantly associated with
work participation in the cancer and general population
groups. Cox proportional hazards modelling with back-
ward removal of variables assessed the hazard of work re-entry (where a hazard ratio of <1 is associated with a lon-
ger time to work resumption) in participants with cancer.
Where a person worked continually through their treat-
ment, we assumed one day was taken off work to enable
these individuals to have an ‘event’ (work resumption),
and be captured in the returned workers category. The
number of days off work was entered as the time variable
in the model, and those permanently retired were ex-
cluded from the analysis. Analyses were stratified by gen-
der but as there negligible differences the data were
subsequently pooled. The proportional-hazards assump-
tion was checked for the multivariable model. Multiple
imputation was employed to handle missing data where
the proportion of missing values was between 5 and 30%
and the number of imputations was equal to or greater
than the percentage of incomplete cases [20]. STATA SE
(Version 12.1) was used for all analyses. Statistical signifi-
cance was at the p < 0.05 level.
Results
Response rates among the cancer group
A total of 1,260 men and women diagnosed with colo-
rectal cancer during the study period and aged 45–64
were identified as potentially eligible for the study. Of
these, 162 were subsequently found to be as ineligible
(i.e., not in paid employment or outside age-group) or
had died. For 393 individuals, doctor’s consent was not
received to enable the researchers to contact potential
participants, and a further 466 individuals did not pro-
vide consent. A lack of response to follow-up letters and
telephone calls was the main reason for non-consent
from both the doctors and potential participants. In
total, 239 men and women were confirmed as eligible
and consented to the study (Figure 1), giving a recruit-
ment rate of 239/1,098 (22%) and a participant response
rate of 239/705 (34%).
Comparison of cancer group participants and
non-participants
A comparison of the participants and non-participants
showed no statistically significant differences for place of
residence, diagnosis by excision or biopsy, cancer site,
histology, cancer grade and AJCC stage. However, a sig-
nificantly higher proportion of participants were male
(n = 159, 67%) versus non-participants (n = 500, 58%)
(p = 0.02). Participants were also slightly younger and
a lower proportion had advanced cancer (Additional
file 1: Table S1).
Comparison of cancer group completers and non-
completers
Analyses comparing the ‘completers’ and ‘non-completers’
of the telephone interviews revealed no statistically signifi-
cant differences in any socio-demographic, cancer or
Figure 1 Participant flow through the study for the cancer group.
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was a similar finding for ‘completers’ and ‘non-completers’
of the postal surveys, with the exception of fewer surveys
being returned by those living in major cities among the
‘non-completers’ (44% vs 51%, p = 0.03).
Baseline characteristics of the cancer group
The mean age of the cancer group was 56 years (SD
5.5), 67% were male, 49% lived in a major city, 81% were
married or partnered and 22% were university educated
(Table 1). In the 136 participants where AJCC stage was
recorded, 46 (34%) had cancer stage I, 40 (29%) had stage
II, 47 (35%) had stage III and 3 (2%) had stage IV. Of the
214 participants that had surgery for their primary treat-
ment, 129 (60%) participants underwent laparoscopic sur-
gery, while 64 (30%) participants were fitted with a stoma
(13 with permanent stomas). Forty participants (19%) ex-
perienced complications during their surgical hospital
stay, and the median length of stay was six days (25–75percentiles: 4–9 days). In terms of adjuvant therapy, 54%
had chemotherapy and 16% had radiotherapy. Twenty-six
participants (20%) reported they were hospitalised for
side-effects attributed to their adjuvant therapy.
Comparison of the cancer and general population group
There were several differences in the baseline charac-
teristics between the cancer and general population
group participants (Table 1) after matching by gender
and 5-year age-group. Participants with cancer were
significantly more likely to be Australian born, less
likely to be widowed or divorced/separated, had lower
education and income levels, and more likely to have
other comorbidity, particularly diabetes or another can-
cer (Table 1).
Employment changes
At baseline, participants with cancer worked significantly
more hours than the general population group (Table 2).
Table 1 Baseline characteristics in the colorectal cancer and general population groups
Cancer General population p1
N = 239 N = 717
Gender Male 160 (67%) 480 (67%) 1.00
Age 45-49 years 35 (15%) 105 (15%) 1.00
50-54 years 51 (21%) 153 (21%)
55-59 years 74 (31%) 222 (31%)
60-64 years 79 (33%) 237 (33%)
Indigenous Yes 3 (1%) 10 (2%) 0.57
Country of birth Australia 180 (81%) 511 (71%) 0.01
Other English-speaking 25 (11%) 112 (16%)
Non-English speaking 17 (8%) 93 (13%)
Rurality Major city 117(49%) 445 (62%) <0.01
Inner regional 66 (28%) 169 (24%)
Outer regional 44 (18%) 85 (12%)
Remote 8 (3%) 13 (2%)
Very remote 4 (2%) 4 (1%)
Marital status Single 22 (10%) 38 (5%) <0.01
Widowed 2 (1%) 18 (3%)
Divorced/separated 19 (9%) 128 (18%)
Married/partnered 179 (81%) 532 (74%)
Highest level of education No formal schooling 1 (1%) 0 (0%) <0.01
Primary school 17 (8%) 23 (3%)
Junior high school 90 (41%) 152 (21%)
Senior high school 36 (16%) 72 (10%)
Trade/technical/diploma 29 (13%) 254 (36%)
University 48 (22%) 215 (30%)
Other co-morbidities Arthritis 40 (18%) 135 (19%) 0.67
Asthma 20 (9%) 53 (8%) 0.49
Cancer (other than colorectal) 29 (13%) 18 (2%) <0.01
Bronchitis/emphysema 11 (5%) 14 (2%) 0.02
Type 2 diabetes 24 (10%) 38 (5%) <0.01
Depression/anxiety 20 (9%) 49 (7%) 0.32
Heart/coronary disease 15 (7%) 25 (4%) 0.04
High blood pressure 56 (25%) 164 (24%) 0.57
Other circ. condition 7 (3%) 8 (1%) 0.04
Household income gross annual in 2010 AUD Less than $ 36400 16 (8%) 85 (12%) <0.01
$ 36400 - $ 77999 54 (28%) 186 (27%)
$ 78000 - $ 103999 47 (24%) 100 (14%)
$ 104000 - above 76 (39%) 326 (47%)
Occupation type Professional/managerial 54 (25%) 303 (42%) <0.01
Skilled clerical/sales 98 (45%) 159 (26%)
Skilled trades/production 64 (30%) 223 (31%)
Work status Full-time (≥32 hours/week) 170 (78%) 526 (76%) 0.54
Part-time (<32 hours/week) 47 (22%) 163 (24%)
Gordon et al. BMC Public Health 2014, 14:963 Page 5 of 11
http://www.biomedcentral.com/1471-2458/14/963
Table 1 Baseline characteristics in the colorectal cancer and general population groups (Continued)
Time (years) worked for current employer Median (25,75%) 8 (3.0,17.0) 10 (3.0,20.0) 0.572
Work schedule Regular daytime 160 (74%) 542 (76%) 0.58
Other 57 (26%) 175 (24%)
Contract type Fixed 17 (8%) 46 (9%) 0.61
Casual 26 (12%) 78 (15%)
Permanent 173 (80%) 412 (77%)
1calculated using chi-squared test; frequencies and proportions displayed, unless otherwise indicated; sums of frequencies can be less than the overall group sizes
due to missing data.
2t-test.
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50 (27%) participants had stopped working (either tem-
porarily or permanently) compared with 53 (8%) partici-
pants in a comparable 12 month period in the general
population group (Table 2). Having colorectal cancer was
the sole reason stated in 71% of participants who stopped
work in the cancer group. A further 45 (32%) participants
with colorectal cancer switched from full- to part-time
work compared with 28 (6%) in the general population
group. A total of 29 participants (20%) with colorectal
cancer reported they had different tasks or responsibilities
in their workplace since being diagnosed with cancer.Table 2 Employment changes over 12 months in the colorect
Colorectal c
N
Hours worked, mean (SD)
- at Baseline n = 217
- at 12 months in those working n = 132
Changes in work hours per week
- ceased work n = 187
- decreased (≥4 hours)
- unchanged (< ± 4 hours)
- increased (≥4 hours)
Days off work4, median (25,75%) n = 102
Full- to part-time5 n = 140
Changes in income
- reduced by >5% n = 92
- increased by >5%
- unchanged or changed by up to ±5%
Occupation changed n = 147
Employer changed n = 147





5full time is defined as working ≥32 hours per week, part time is <32 hours per weeEmployment among the cancer group
In the cancer group, similar proportions of men and
women ceased work, reduced their work hours, or main-
tained their work hours from baseline to 12 months. At
six months, paid sick leave accounted for 51% of income
support during previous time away from work due to can-
cer, 24% was taken as annual leave, 6% as long-service
leave, 18% as income protection insurance and the re-
mainder as ‘other’ type of payment. Respondents reported
various workplace arrangements to accommodate their
absence including: employing a temporary staff member
(36%), existing staff worked longer (33%), working fromal cancer and general population groups
ancer General population p
n (%)1 N = 717
42.4 (15.9) 38.6 (14.4) <0.012
38.2 (15.3) 38.7 (14.3) 0.732
50 (27%) 53 (8%) <0.013
36 (19%) 156 (23%)
99 (53%) 377 (55%)
2 (1%) 101 (15%)
91 (14,183) N/A -
45 (32%) 28 (6%) <0.013
17 (19%) 111 (24%) <0.013
3 (3%) 189 (42%)
72 (78%) 156 (34%)
15 (10%) 43 (7%) 0.123
11 (8%) 30 (5%) 0.193
29 (20%) N/A -
k.
Table 3 Correlates of work cessation at 12 months (significant variables in the models shown only)









OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Age1 1.16*** (1.09,1.24) 1.15*** (1.06,1.25) 1.08* (1.00,1.16) 1.08* (1.00,1.16)
Gender
- male 1.00 - 1.00 -
- female 2.26** (1.29,3.97) 0.92 (0.46,1.81)
BMI1 1.02 (0.96,1.08) 0.92* (0.84,0.99) 0.91* (0.84,0.99)
Education
- junior/high school 1.00 - 1.00 - 1.00 -
- trade/vocational 0.50* (0.26,0.96) 0.30* (0.12,0.76) 0.76 (0.28,2.07)
- university 0.38* (0.18,0.81) 0.32* (0.12,0.88) 0.28* (0.09,0.86)
Child/ren in household
- no 1.00 - 1.00 -
- yes 0.09* (0.01,0.65) 0.37 (0.10,1.30)
People in household
- 1 1.00 - 1.00 -
- 2 0.95 (0.48,1.87) 1.05 (0.34,3.23)
- 3 0.17** (0.05,0.59) 0.65 (0.16,2.60)
- 4 or more 0.14** (0.04,0.52) 0.34 (0.08,1.50)
Comorbidities
- none 1.00 - 1.00 -
- 1 2.06* (1.06,3.99) 0.65 (0.27,1.55)
- 2 2.76* (1.21,6.28) 1.26 (0.47,3.38)
- 3 or more 1.20 (0.27,5.44) 2.14 (0.81,5.66)
Occupation group
- professional/managerial 1.00 - 1.00 -
- skilled services 1.93 (0.92,4.06) 3.09* (1.08,8.82)
- skilled trades 2.39* (1.20,4.75) 2.88 (0.96,8.66)
Employer size
- <20 staff 1.00 - 1.00 -
- 20 to 100 staff 0.62 (0.29,1.32) 2.10 (0.98,4.53)
- >100 staff 0.28** (0.11,0.70) 1.57 (0.52,4.77)
- 1 (self-employed) 1.47 (0.71,3.07) 1.12 (0.11,10.82)
Time at employer1 (years) 0.94*** (0.90,0.97) 0.94* (0.89,0.99) 1.02 (0.99,1.04)
Work contract
- permanent 1.00 - 1.00 - 1.00 -
- other 4.28*** (2.18,8.39) 4.57*** (2.05,10.16) 1.89 (0.85,4.24)
Work autonomy2 0.88 (0.72,1.08) 0.47** (0.28,0.77)
Household income
- > $104,000 1.00 - 1.00 - 1.00 -
- < $78,000 5.92*** (2.56,13.67) 1.40 (0.52,3.82) 2.20 (0.96,5.02)
- $78,000 to $104,000 6.19*** (2.37,16.20) 4.13** (1.42,12.03) 1.15 (0.43,3.04)
Income group
- $36,000 to $78,000 1.00 - 1.00 -
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Table 3 Correlates of work cessation at 12 months (significant variables in the models shown only) (Continued)
- > $78,000 0.25*** (0.12,0.52) 1.25 (0.48,3.27)
- < $36,000 0.09*** (0.03,0.31) 0.90 (0.32,2.59)
Energy3
- none/little of the time 1.00 - 1.00 -
- some/good bit of the time 0.46 (0.21,0.98) 0.48 (0.21,1.10)
- most/all of the time 0.57 (0.26,1.21) 0.18*** (0.07,0.45)
Mental Component Score4 0.99 (0.96,1.03) 0.98 (0.95,1.01)
Physical Component Score4 0.96*** (0.93,0.98) 0.92*** (0.89,0.95) 0.93***5 (0.90,0.97)
1centred over mean.
2continuous variable, centred over mean, the higher the number the more flexibility the person has regarding their work hours, tasks performed, taking
breaks etc.
3from the SF-12 scale asking respondents ‘did you have a lot of energy?’ in the past 4 weeks.
4continuous variable, centred over mean, from the SF-12 scale, higher scores reflect higher quality of life.
5multiple imputation of missing values.
*P < 0.05, **P < 0.01, ***P < 0.001.
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working longer days to make up for any time off.
Factors associated with stopping work at 12 months
Individuals with colorectal cancer were more likely to
stop work at 12 months if they were older, had lower
body mass index (BMI), and/or lower physical well-
being (Table 3). Cancer-specific factors (e.g., cancer site,
stage, grade, surgical complications, length of hospital
stay) or occupational factors were not associated with
stopping work at 12 months (not shown). Individuals of
the same age and gender from the general population
were more likely to stop work if they were: older, did not
study a trade or further education after high school,
shorter tenure with employer, did not have a permanent
work contract or were in a middle-income bracket.
Factors associated with time to work resumption among
cancer group
Participants with cancer who returned to work took a me-
dian of 91 days off work (25–75 percentiles: 14–183 days).
Factors associated with delayed work re-entry after cancer
included not being university-educated, poorer perceived
financial status, working for a employer with more than
20 employees in a non-professional or non-managerial
role, longer hospital stay, and chemotherapy (currently
undergoing or treatment completed) (Table 4).
Discussion and conclusions
This is the first study to assess the work outcomes of
men and women diagnosed with colorectal cancer dur-
ing middle adulthood (45–64 years). During this pre-
retirement phase, individuals with cancer were three and
a half times more likely to have stopped work compared
with an age and gender-matched group from the general
population. This finding should be tempered by a pro-
portion of those individuals who do not want to returnto their workplace. Of those who returned, 20% reported
having different work tasks and responsibilities. Only older
age (but still below the retirement age of 65 years), poorer
self-reported physical health and lower BMI (perhaps
linked with poorer physical health) were associated with
stopping work at 12 months for those with colorectal can-
cer however a range of occupational, socio-demographic
and clinical factors were linked with a more timely work
re-entry.
Our research indicates that while many individuals
were able to return to work by 12 months (a few even
working through their treatment regimes) many changes
occurred and these changes were similar across genders.
Job tasks, employer accommodations and reduced work
hours were examples of work-related changes, and 27%
of workers ceased work following their colorectal cancer
diagnosis. A further 32% of participants with colorectal
cancer switched to part-time work 12 months after diag-
nosis. Workplace arrangements were made in 78% of the
participant group to accommodate interruptions to re-
ceive treatment. The implications of these events suggest
that employers will need to be prepared for more flexible
arrangements as employees require time off work. The
model by Steiner et al. that advocates a wider social ap-
proach to examining work outcomes for cancer survi-
vors, integrated with patient, socio-demographic factors,
is indeed highly relevant [19]. This is due to our findings
showing significant factors associated with work return
crossing all three of these domains.
Four previous studies have specifically focused on in-
dividuals with colorectal cancer and employment par-
ticipation outcomes [5,6,9,21]. Other studies involving
individuals with colorectal cancer assess different out-
comes such as financial burden [22-25], perceived work
ability [4]. Our study avoided some of the limitations of
prior studies, namely, the use of cross-sectional designs
[10], the use of an indirect measurement of return to
Table 4 Factors associated with time to work resumption1 among participants with colorectal cancer (significant
variables shown only)
Univariable n = 195 Multivariable n = 186
HR 95% CI HR 95% CI
Education
- junior/high school 1.00 - 1.00 -
- trade/vocational 0.97 (0.56,1.68) 1.11 (0.62,1.99)
- university 1.91** (1.30,2.81) 1.76* (1.09,2.83)
Perceived prosperity
- poor/just getting along 1.00 - 1.00 -
- reasonably comfortable 2.04** (1.25,3.32) 1.80*2 (1.05,3.09)
- very comfortable/prosperous 2.84*** (1.55,5.22) 1.892 (0.93,3.87)
Employer size
- 20 to 100 staff 1.00 - 1.00 -
- <20 staff 1.46 (1.00,2.14) 1.66* (1.09,2.53)
- >100 staff 1.80* (1.09,2.96) 1.47 (0.83,2.60)
Occupation group
- skilled services 1.00 - 1.00 -
- skilled trades 0.77 (0.50,1.20) 1.05 (0.65,1.68)
- professional/managerial 1.85** (1.24,2.76) 1.60* (1.02,2.52)
Stoma fitted
- no 1.00 -
- yes 0.50** (0.33,0.76)
Surgery complications
- no 1.00 -
- yes 0.57* (0.35,0.92)
Hospital length of stay3(days) 0.94** (0.90,0.98) 0.93** (0.89,0.97)
Chemotherapy
- none 1.00 - 1.00 -
- currently undergoing 0.35*** (0.23,0.53) 0.29*** (0.19,0.45)
- treatment completed 0.36*** (0.21,0.61) 0.32*** (0.18,0.57)
Radiotherapy
- none 1.00 -
- any 0.47* (0.26,0.85)
Energy4
- none/little of the time 1.00 -
- some/good bit of the time 2.16** (1.32,3.51)
- most/all of the time 2.28** (1.36,3.80)
1study period ended at 12 months after diagnosis, therefore the time to work resumption data from those temporarily retired (still planning to return to work) at
12 months were censored at the end of the study period.
2multiple imputation of missing values.
3centred over mean.
4from the SF-12 scale asking respondents ‘did you have a lot of energy?’ in the past 4 weeks; HR (hazard ratio) <1 means lower hazard of work re-entry, ie. longer
time off-work, controlling for the other variables; HR > 1 associated with shorter time off-work, controlling for the other variables.
*P < 0.05, **P < 0.01, ***P < 0.001.
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and the associated inability to isolate the natural effects
of ageing, retirement choice and labor force changes.
Our findings agreed with the results of these studies interms of chemotherapy, older age, advanced stage and
lower socio-economic indicators being impediments to
work participation. However, two studies [6,21] found
higher rates of colorectal cancer survivors who were
Gordon et al. BMC Public Health 2014, 14:963 Page 10 of 11
http://www.biomedcentral.com/1471-2458/14/963not working at 12 months (range 33-40%) while an-
other was similar to our results (17%) [5].
The strengths of our study include a population-based
recruitment approach, the use of validated instruments,
the inclusion of a non-cancer general population group
(HILDA) and utilising both a prospective and retrospect-
ive design. We chose colorectal cancer because this cancer
type is the most common to both men and women. Tele-
phone interviews were undertaken in order to reach a
wide geographical region and minimise participant bur-
den, the latter being important in a working population
that may require out-of-hours contact. We also included
many items covering the context of people’s workplaces
that have rarely been studied in the relationship between
cancer and employment.
Our findings present a starting point from which to
understand the nature of colorectal cancer upon work, the
impact and the adaptations patients and employers make
when facing this disease. The implications suggest that
employers will need to be prepared for more flexible ar-
rangements as employees require time off work. Em-
ployers may need to plan for an absence of around three
months with many taking up to six months off and others
even longer. Longer time off is necessary for those in
blue-collar or physical occupations. Clear discussions be-
tween patients and employers on capacity to work and
each party’s expectations will facilitate this planning [26].
More broadly, it is critical that the Government is pre-
pared to address issues around the impending loss of
skilled people from the workforce with chronic illnesses.
Australia’s ageing population will reduce productivity dur-
ing the next few decades with the ratio of adults not in
employment to those in employment continuing to rise.
Yet it appears that the Government is slow to make deci-
sions that meet the challenges of an ageing population
[27]. Rehabilitation and retraining programs to assist pa-
tients return to work as part of broader policies to in-
crease work participation after acute illness or injury
should be more attractive than increasing welfare pay-
ments or taxes. Rehabilitation and retraining programs are
likely to create specific, sustainable and positive work re-
tention measures and avoid incentivizing long-term work
departure with welfare support.
Our study has a number of limitations. Our response
rate was low. Possible reasons include the target group
was too ill at the recruitment time or too time-poor with
little capacity to join a research project. Many partici-
pants completed their interviews during work time or
while receiving intravenous chemotherapy in their out-
patient clinic appointments. However, in terms of their
health, in general the non-participants had similar clin-
ical presentations than participants. Another limitation
was we did not ask whether individuals had a cancer re-
currence during the study period and whether they hadtold their employer about their diagnosis. Finally, recent
qualitative work has raised questions of personality and
motivational factors being strong drivers for individuals
in the return to their workplace after illness [27], which
our study did not assess.
In conclusion, for middle-aged working men and women
diagnosed with colorectal cancer, one in four were not
working at 12 months after diagnosis compared with one
in ten without cancer. Individuals with no tertiary educa-
tion, who were undertaking chemotherapy and/or in large
workplaces could be targeted for specific assistance for fas-
ter return to work after colorectal cancer.
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